৳ ০.০০
আপনার সব স্বাস্থ্যসেবার সমাধান — এখন এক জায়গাতেই
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬
৳ ০.০০
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬


Quantity:
Products
Payment
Delivery
Indicated for the treatment of signs and symptoms of Benign Prostatic Hyperplasia (BPH) in men with an enlarged prostate, for up to 26 weeks.
Finasteride: A specific inhibitor of steroid Type II 5α‑reductase. This enzyme converts testosterone into dihydrotestosterone (DHT). By lowering DHT levels, Finasteride reduces prostate growth and leads to shrinkage of the enlarged prostate gland.
Tadalafil: A selective inhibitor of phosphodiesterase type‑5 (PDE5). It relaxes smooth muscles of the prostate and surrounding urethra, improving urine flow and reducing BPH symptoms.
Adults: One capsule orally once daily at the same time, preferably on an empty stomach, for up to 26 weeks. Not recommended beyond 26 weeks.
Pediatric Use: Not established for patients under 18 years.
Geriatric Use: No significant differences in safety or efficacy observed in patients ≥65 years.
Hepatic Impairment: Use with caution in moderate impairment; not recommended in severe impairment.
Renal Impairment: Not recommended if creatinine clearance <50 mL/min or in patients undergoing hemodialysis.
Nitrates: Contraindicated with organic nitrates due to risk of severe hypotension.
Alpha‑Blockers: Caution advised. Discontinue alpha‑blockers at least one day before starting Urotide for BPH treatment.
Finasteride + Tadalafil is a combination medicine used mainly for benign prostatic hyperplasia (BPH), a condition where the prostate becomes enlarged. Finasteride reduces prostate size by blocking conversion of testosterone to dihydrotestosterone (DHT), while tadalafil relaxes smooth muscles in the prostate and bladder to improve urine flow.
This combination helps improve urinary symptoms of BPH such as weak urine flow, frequent urination, and nighttime urination. It may also help improve erectile function due to tadalafil.




